Home / Companies / West Pharmaceutical Services, Inc. / 4 May 2026
West Pharmaceutical Services, Inc.: meeting of 4 May 2026
Votes reported on Form N-PX, item by item
904 Form N-PX filers reported votes at the West Pharmaceutical Services, Inc. meeting of 4 May 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
11 nominees; 94.0% of reported votes for; 27 filers withheld from or voted against at least one nominee.
7,551 vote records from 248 filers. 4 of the 247 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,505 vote records from 899 filers. 58 of the 870 filers that marked the item either way voted against management. 29 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
685 vote records from 247 filers. 4 of the 246 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCESecurity holder
Shareholder proposal regarding an independent Board Chair policy.
665 vote records from 242 filers. 126 of the 241 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
1 vote records from 1 filers. 1 of the 1 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 4. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | Against |
| BlackRock and iShares | For | For | For | Against |
| Fidelity | For | For | For | Against |
| Dimensional | For | For | For | Against |
| State Street and SPDR | For | For | For | Against |
| American Century | For | For | For | Against |
| Franklin Templeton | For | For | For | For * |
| Invesco | For | For | For | For * |
| Equitable | For | For | For | For * |
| Charles Schwab | For | For | For | Against |
| Nuveen and TIAA | For | For | For | Against |
| ProShares and ProFunds | For | For | For | For * |
| John Hancock and Manulife | For | For | For | Against |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For | For * |
| J.P. Morgan | For | For | For | Against |
| Goldman Sachs | For | For | For | Against |
| WisdomTree | For | For | For | Against |
| PGIM and Prudential | For | For | For | For * |
| Jackson National funds | For | For | For | For * |
| Northern Trust and FlexShares | For | For | For | Against |
| SEI | For | For | For | For * |
| T. Rowe Price | For | For | For | For * |
| Thrivent | For | For | For | Against |
| Lincoln Financial | For | For | For | Against * |
| Voya | For | For | For | Against |
| First Trust | For | For | For | For * |
| Russell Investments | For | For | For | For * |
| Nationwide | For | For | For | For * |
| Victory Capital | For | For | For | For * |
| Brighthouse Funds | For | For | For | For * |
| Guggenheim and Rydex | For | For | For | For * |
| Columbia Threadneedle | For | For | For | For * |
| BNY Mellon | For | For | For | Against |
| Principal | For | For | For | Against |
| Capital Group and American Funds | For | For | For | For * |
| Pacific Life funds | For | For | For | Against |
| Global X | For | For | For | For * |
| Transamerica | For | For | For | Against |
| Federated Hermes | For | For | For | For * |
| AllianceBernstein | For | For | For | For * |
| Hartford Funds | For | For | For | For * |
| DWS | For | For | For | For * |
| PIMCO | For | For | For | For * |
| Allspring | For | For | For | For * |
| MassMutual | For | For | For | For * |
| Virtus | For | For | For | For * |
| VanEck | For | For | For | For * |
| Macquarie and Delaware Funds | No report | For | No report | No report |
| Janus Henderson | No report | For | No report | No report |
| Neuberger Berman | For | For | For | For * |
| Natixis and Loomis Sayles | No report | For | No report | No report |
| Baird | For | For | For | For * |
| Artisan Partners | For | For | For | Against |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the West Pharmaceutical Services, Inc. meeting?
904 Form N-PX filers reported votes at the meeting of 4 May 2026. On say-on-pay, 58 of 870 voted against management (6.7%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by West Pharmaceutical Services, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for West Pharmaceutical Services, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing West Pharmaceutical Services, Inc. with a meeting date within three days of 4 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.